Abstract:OBJECTIVE:To study the function and prognostic value of the recently identified tumor suppressor gene LKB1 in human breast cancer.METHODS:Estrogen receptor-positive human breast cancer cells of MCF-7 line and estrogen receptor-negative human breast cancer cells of the lines MDA-MB-435 and MDA-MB-231 were cultured and tested for the LKB1 expression. Plasmid pcDNA4 TOPO HisMAX/LKB1 expressing LKB1 was constructed and transfected into the MDA-MB-435 cells. PCR and Western blotting were used to detect the expressions of LKB1 mRNA and protein. Flow cytometry was used to determine the cell cycle. PCR and Western blotting were used to detect the expressions of LKB1 mRNA and protein in 121 human breast cancer samples. The association with relapse free survival (RFS) and overall survival (OS) was assessed by univariate analysis (log-rank test and Kaplan-Meier method).RESULTS:Human breast cells of MCF-7 line expressed LKB1 and the cells of MDA-MB-435 and MDA-MB-231 lines did not. Flow cytometry showed that 40.9% of the MDA-MB-435 transfected with pcDNA4 TOPO HisMAX/LKB1 was at the G(1) stage, a proportion significantly higher than that of the control (18.3%). The expressions of cyclin D1 and cyclin E were significantly down-regulated and the expression of p21(WAF1/CIP1) was significantly up-regualed. LKB1 was lowly expressed in 43 out of the 121 cases of breast cancer (35.4%) and highly expressed in 78 cases (64.6%). Low expression of LKB1 was correlated with pathological grade (P = 0.013), cancer size (P = 0.001), status of estrogen receptor (P = 0.048), and status of lymph nodes metastasis (P = 0.003). Univariate analysis showed that low expression of LKB1 was significantly correlated with shorter RFS (P = 0.048) and low OS (P = 0.003).CONCLUSION:Reintroducing LKB1 into breast cell of the lines lacking LKB1 expression restores LKB1 activity and induces growth suppression by G(1) cell cycle block. The LKB1 mediated G(1) cell cycle arrest is caused by up-regulation of the expression of p21(WAF1/CIP1) in MDA-MB-435 breast cancer cells.

Advance of the research in the tumor suppressor gene LKB1

Progress in antitumor mechanisms of liver kinase B1 gene

Posttranslational regulation of liver kinase B1 in human cancer

Recent progress on liver kinase B1 (LKB1): expression, regulation, downstream signaling and cancer suppressive function.

The Tumor Suppressor Gene Lkb1 Is Associated With Prognosis In Human Breast Carcinoma

LKB1 and Cancer: the Dual Role of Metabolic Regulation.

Enhanced Expression of LKB1 in Breast Cancer Cells Attenuates Angiogenesis, Invasion, and Metastatic Potential

LKB1 inactivation leads to centromere defects and genome instability via p53-dependent upregulation of survivin.

Expression and transcriptional profiling of the LKB1 tumor suppressor in cervical cancer cells.

LKB 1 Gene Mutation and Cancer Incidence in Peutz-Jeghers Patients

LKB1 is a DNA damage response protein that regulates cellular sensitivity to PARP inhibitors.

The Peutz-Jegher Gene Product LKB1 is a Mediator of P53-Dependent Cell Death.

[Function and Prognostic Value of Tumor Suppressor Gene LKB1 in Human Breast Carcinoma].

Liver kinase B1 regulates the centrosome via PLK1

LKB1 and lung cancer: more than the usual suspects

Germline Mutations of the Lkb1 (stk11) Gene in Peutz-Jeghers Patients

LKB1 Modulates Lung Cancer Differentiation and Metastasis.

Clinical significance and role of LKB1 in gastric cancer.

Molecular chaperone complexes with antagonizing activities regulate stability and activity of the tumor suppressor LKB1

LKB1 biology: assessing the therapeutic relevancy of LKB1 inhibitors

Loss of Heterozygosity of LKB1 in Tumors from Peutz-Jeghers Syndrome Patients and Its Cancer Predisposing Mechanism